The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
Open accessAbstract
GPER/GPR30 is a seven-transmembrane G protein-coupled estrogen receptor that regulates many aspects of mammalian biology and physiology. We have previously described both a GPER-selective agonist G-1 and antagonist G15 based on a tetrahydro-3H-cyclopenta[c]quinoline scaffold. The antagonist lacks an ethanone moiety that likely forms important hydrogen bonds involved in receptor activation. Computational docking studies suggested that the lack of the ethanone substituent in G15 could minimize key steric conflicts, present in G-1, that limit binding within the ERα ligand binding pocket. In this report, we identify low-affinity cross-reactivity of the GPER antagonist G15 to the classical estrogen receptor ERα. To generate an antagonist with enhanced selectivity, we therefore synthesized an isosteric G-1 derivative, G36, containing an isopropyl moiety in place of the ethanone moiety. We demonstrate that G36 shows decreased binding and activation of ERα, while maintaining its antagonist profile towards GPER. G36 selectively inhibits estrogen-mediated activation of PI3K by GPER but not ERα. It also inhibits estrogen- and G-1-mediated calcium mobilization as well as ERK1/2 activation, with no effect on EGF-mediated ERK1/2 activation. Similar to G15, G36 inhibits estrogen- and G-1-stimulated proliferation of uterine epithelial cells in vivo. The identification of G36 as a GPER antagonist with improved ER counterselectivity represents a significant step towards the development of new highly selective therapeutics for cancer and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302
Self-citationFilardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Self-citationKousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 746
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., & Hathaway, H. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100518 · Cited by 590
Self-citationIn vivo effects of a GPR30 antagonist
Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.168 · Cited by 532
Self-citationREGULATION OF SIGNAL TRANSDUCTION PATHWAYS BY ESTROGEN AND PROGESTERONE
Edwards, D. P. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120151 · Cited by 502
Brailoiu, E., Dun, S. L., Brailoiu, G. C., Mizuo, K., Sklar, L. A., Oprea, T. I., Prossnitz, E. R., & Dun, N. J. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0017 · Cited by 501
Self-citationAlbanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Self-citationRegulatory role of G protein-coupled estrogen receptor for vascular function and obesity
Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190892 · Cited by 373
Self-citationEstrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., & Picard, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.304 · Cited by 327
Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis
Blasko, E., Haskell, C. A., Leung, S., Gualtieri, G., Halks-Miller, M., Mahmoudi, M., Dennis, M. K., Prossnitz, E. R., Karpus, W. J., & Horuk, R. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.023 · Cited by 181
Self-citationGingerich, S., Kim, G. L., Chalmers, J. A., Koletar, M. M., Wang, X., Wang, Y., & Belsham, D. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.076 · Cited by 171
Noel, S. D., Keen, K. L., Baumann, D. I., Filardo, E. J., & Terasawa, E. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0299 · Cited by 171
Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Proctor, T., Vandenbark, A. A., & Offner, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803205 · Cited by 156
GPR30: a novel therapeutic target in estrogen-related disease
Prossnitz, E. R., Sklar, L. A., Oprea, T. I., & Arterburn, J. B. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.001 · Cited by 137
Self-citationGill, A., Jamnongjit, M., & Hammes, S. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0326 · Cited by 136
Lange, C. A., Gioeli, D. G., Hammes, S. R., & Marker, P. C. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160319 · Cited by 113
Lindsey, S. H., Carver, K. A., Prossnitz, E. R., & Chappell, M. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182135f1c · Cited by 107
Self-citationGao, F., Ma, X., Ostmann, A. B., & Das, S. K. (2011) · Endocrinology · doi:10.1210/en.2010-1368 · Cited by 106
Peyton, C., & Thomas, P. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.110.088765 · Cited by 94
GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat
Kuhn, J., Dina, O. A., Goswami, C., Suckow, V., Levine, J. D., & Hucho, T. B. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06131.x · Cited by 88
The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell Proliferation
Teng, J., Wang, Z., Prossnitz, E. R., & Bjorling, D. E. (2008) · Endocrinology · doi:10.1210/en.2007-1669 · Cited by 66
Self-citationHigh‐throughput flow cytometry: Validation in microvolume bioassays
Ramírez, S., Aiken, C. T., Andrzejewski, B. P., Sklar, L. A., & Edwards, B. S. (2003) · Cytometry Part A · doi:10.1002/cyto.a.10035 · Cited by 59
Self-citationEstradiol inhibits chondrogenic differentiation of mesenchymal stem cells via nonclassic signaling
Jenei‐Lanzl, Z., Straub, R. H., Dienstknecht, T., Huber, M., Hager, M., Grässel, S., Kujat, R., Angele, M. K., Nerlich, M. L., & Angele, P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27328 · Cited by 59
Tumor-Stromal Interaction through the Estrogen-Signaling Pathway in Human Breast Cancer
Yamaguchi, Y., Takei, H., Suemasu, K., Kobayashi, Y., Kurosumi, M., Harada, N., & Hayashi, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3236 · Cited by 59
Self-citationBurai, R., Ramesh, C., Shorty, M., Curpan, R. F., Bologa, C., Sklar, L. A., Oprea, T. I., Prossnitz, E. R., & Arterburn, J. B. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c001307b · Cited by 42
Self-citation
Cited by
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Estrogen biology: New insights into GPER function and clinical opportunities
Prossnitz, E. R., & Barton, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.002 · Cited by 400
Self-citationProssnitz, E. R., & Arterburn, J. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009712 · Cited by 258
Self-citationThe G protein-coupled oestrogen receptor GPER in health and disease: an update
Prossnitz, E. R., & Barton, M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00822-7 · Cited by 231
Self-citation
Metadata
- Authors
- Dennis, M. K., Field, A. S., Burai, R., Ramesh, C., Petrie, W. K., Bologa, C. G., Oprea, T. I., Yamaguchi, Y., Hayashi, S.-I., Sklar, L. A., Hathaway, H. J., Arterburn, J. B., & Prossnitz, E. R.
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 127
- Issue
- 3-5
- Pages
- 358-366
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W1983349129
- Cited by
- 311
- References
- 29
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.